After early Semaglutide lead, Torrent Pharma eyes US liver drug Resmetirom for India launch

Resmetirom is the first approved therapy in the US specifically for MASH, earlier known as NASH—a progressive fatty liver disease linked to obesity, diabetes and poor metabolic health

Raccontata dathehindubusinessline.com